Positive Expression of SMYD2 is Associated with Poor Prognosis in Patients with Primary Hepatocellular Carcinoma

Purpose: SET and MYND domain-containing protein2 (SMYD2), a histone lysine methyltransferases, is a candidate human oncogene in multiple tumors. However, the expression dynamics of SMYD2 in hepatocellular carcinoma (HCC) and its clinical/prognostic significance are unclear. Methods: The SMYD2 expres...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuo, Shan-Ru, Zuo, Xiao-Cong, He, Yang, Fang, Wei-Jin, Wang, Chun-Jiang, Zou, Heng, Chen, Pan, Huang, Ling-Fei, Huang, Li-Hua, Xiang, Hong, Liu, Shi-Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771340/
https://www.ncbi.nlm.nih.gov/pubmed/29344279
http://dx.doi.org/10.7150/jca.22218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771340/
https://www.ncbi.nlm.nih.gov/pubmed/29344279
http://dx.doi.org/10.7150/jca.22218

Ejemplares similares